Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of eslicarbazepine acetate on cognition in children with partial-onset seizures
2008-005606-39Phase 2Withdrawn
- Sponsor
- BIAL
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Focal Onset Epilepsy comparing Eslicarbazepine acetate add-on with Placebo add-on (2 arms). Primary endpoint: Change in composite Power of Attention. Planned start Jul 2009; status: withdrawn.
02
Drugs
eslicarbazepine acetate
03
Conditions
Focal Onset Epilepsy
Beyond the preview
Go deeper on 2008-005606-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005606-39.